An miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)

Vilmont, V.Aebischer, J.Rochat, C.Schneider, B. L.2019-01-032019-01-032019-01-032018-12-01https://infoscience.epfl.ch/handle/20.500.14299/153281WOS:000453707700257Biotechnology & Applied MicrobiologyGenetics & HeredityMedicine, Research & ExperimentalResearch & Experimental MedicineAn miRNA-based gene therapy approach to target mutated SOD1 in key cell types in amyotrophic lateral sclerosis (ALS)text::conference output::conference proceedings::conference paper